Your browser doesn't support javascript.
loading
The real-world use and efficacy of pomalidomide for relapsed and refractory multiple myeloma in the era of CD38 antibodies.
Szabo, Agoston Gyula; Thorsen, Jonathan; Iversen, Katrine Fladeland; Levring, Mette Bøegh; Helleberg, Carsten; Hermansen, Emil; Bønløkke, Søren Thorgaard; Nielsen, Katrine; Teodorescu, Elena Manuela; Kurt, Eva; Strandholdt, Casper Nørgaard; Vangsted, Annette Juul.
Afiliação
  • Szabo AG; Department of Hematology Vejle Hospital Vejle Denmark.
  • Thorsen J; Department of Hematology, Rigshospitalet Copenhagen University Copenhagen Denmark.
  • Iversen KF; COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital University of Copenhagen Copenhagen Denmark.
  • Levring MB; Department of Hematology Vejle Hospital Vejle Denmark.
  • Helleberg C; Department of Hematology Odense University Hospital Odense Denmark.
  • Hermansen E; Department of Hematology, Rigshospitalet Copenhagen University Copenhagen Denmark.
  • Bønløkke ST; Department of Hematology, Rigshospitalet Copenhagen University Copenhagen Denmark.
  • Nielsen K; Department of Hematology Zealand University Hospital Roskilde Denmark.
  • Teodorescu EM; Department of Hematology Aarhus University Hospital Aarhus Denmark.
  • Kurt E; Department of Hematology Aarhus University Hospital Aarhus Denmark.
  • Strandholdt CN; Department of Hematology Aalborg University Hospital Aalborg Denmark.
  • Vangsted AJ; Department of Hematology Regionshospitalet Gødstrup Herning Denmark.
EJHaem ; 4(4): 1006-1012, 2023 Nov.
Article em En | MEDLINE | ID: mdl-38024635

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: EJHaem Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: EJHaem Ano de publicação: 2023 Tipo de documento: Article